筛查结肠镜检查发现的腺瘤的恶性风险
基于德国国家筛查结肠镜登记处2007—2012年数据,回顾性分析2,532,298次筛查结肠镜中594,614枚腺瘤,发现高级别异型增生(HGD)腺瘤20,873枚(3.5%);近端与远端腺瘤HGD率相似,腺瘤大小是最强危险因素(OR 10.36,≥1 cm vs <1 cm)。
要点
- 近端腺瘤位置与更高的HGD率无关。
- 腺瘤大小是最强HGD危险因素(OR 10.36,≥1 cm vs <1 cm)。
- 患者年龄和男性与HGD率升高相关。
核心结论
- 在该大型筛查数据库中,近端与远端结肠腺瘤伴HGD的比率相似。
- 仅以HGD作为风险标志不能解释近端间期结直肠癌发生率更高。
- 作者认为近端结肠可能遗漏某些病变(平坦、锯齿状病变),且其生物学行为可能随时间更具侵袭性;内镜相关因素与生物学共同解释近端与远端间期结直肠癌发生率差异。
研究设计与样本
- 回顾性分析2007—2012年德国国家筛查结肠镜登记处数据,包括2,532,298次筛查结肠镜中发现的594,614枚腺瘤。
- 主要结局指标为腺瘤中高级别异型增生(HGD)率,作为恶性风险的替代标志。
- 采用多因素分析计算腺瘤HGD率与患者及腺瘤相关因素的比值比(OR)。
主要发现
- 20,873枚腺瘤(3.5%)检出HGD组织学。
- 近端腺瘤位置与更高的HGD率无关。
- 腺瘤大小是最显著HGD危险因素(OR 10.36,≥1 cm vs <1 cm)。
- 患者年龄65—74岁和75—84岁 vs 55—64岁的OR分别为1.26和1.46;男性 vs 女性OR 1.15。
- 以平坦腺瘤为参照,无蒂病变HGD率相似(OR 1.02),有蒂腺瘤HGD率更高(OR 1.23);所有关联均具有统计学显著性(P ≤ .05)。
关键数值与推荐
- HGD腺瘤20,873枚(3.5%)。
- 腺瘤大小OR 10.36(≥1 cm vs <1 cm)。
- 年龄65—74岁 vs 55—64岁OR 1.26;75—84岁 vs 55—64岁OR 1.46。
- 男性 vs 女性OR 1.15。
- 无蒂病变 vs 平坦腺瘤OR 1.02;有蒂腺瘤 vs 平坦腺瘤OR 1.23;所有P ≤ .05。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: A higher incidence of proximal interval cancers after colonoscopy has been reported in several follow-up studies. One possible explanation for this might be that proximally located adenomas have greater malignant potential. The aim of the present study was to assess the risk of malignancy in proximal versus distal adenomas in patients included in a large screening colonoscopy database; adenoma shape and the patients' age and sex distribution were also analyzed. METHODS: Data for 2007-2012 from the German National Screening Colonoscopy Registry, including 594,614 adenomas identified during 2,532,298 screening colonoscopies, were analyzed retrospectively. The main outcome measure was the rate of high-grade dysplasia (HGD) in adenomas, used as a surrogate marker for the risk of malignancy. Odds ratios (ORs) for the rate of HGD found in adenomas were analyzed in relation to patient- and adenoma-related factors using multivariate analysis. RESULTS: HGD histology was noted in 20,873 adenomas (3.5%). Proximal adenoma locations were not associated with a higher HGD rate. The most significant risk factor for HGD was adenoma size (OR 10.36 ≥1 cm vs <1 cm), followed by patient age (OR 1.26 and 1.46 for age groups 65-74 and 75-84 vs 55-64 years) and sex (OR 1.15 male vs female). In comparison with flat adenomas as a reference lesion, sessile lesions had a similar HGD rate (OR 1.02) and pedunculated adenomas had a higher rate (OR 1.23). All associations were statistically significant (P ≤ .05). CONCLUSIONS: In this large screening database, it was found that the rates of adenomas with HGD are similar in the proximal and distal colon. The presence of HGD as a risk marker alone does not explain higher rates of proximal interval colorectal cancer. We suggest that certain lesions (flat, serrated lesions) may be missed in the proximal colon and may acquire a more aggressive biology over time. A combination of endoscopy-related factors and biology may therefore account for higher rates of proximal versus distal interval colorectal cancer.
引用
- Rösch T, Altenhofen L, Kretschmann J, et al. Risk of Malignancy in Adenomas Detected During Screening Colonoscopy. Clin Gastroenterol Hepatol. 2018. PMID: 29902640. doi:10.1016/j.cgh.2018.05.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。